Clinical Trials Directory

Trials / Unknown

UnknownNCT02951208

tDCS Coupled With Virtual Rehabilitation for Negative Symptoms in At-Risk Youth

Transcranial Direct Current Stimulation Coupled With Virtual Rehabilitation for Negative Symptoms in At-Risk Youth

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
22 (estimated)
Sponsor
Centre for Addiction and Mental Health · Academic / Other
Sex
All
Age
16 Years – 30 Years
Healthy volunteers
Not accepted

Summary

Negative symptoms, which include the loss of motivation, social withdrawal and reduced emotional expression are prominent in youth at clinical high risk (CHR) for psychosis. These negative symptoms lead to significant functional impairment and enduring disability in these youth. At present, there are no established treatments for negative symptoms. Recent evidence from independent studies, however, suggests two promising novel treatment approaches for negative symptoms, transcranial direct current stimulation (tDCS), and computerized remediation strategies. The primary aim of this study is to evaluate if tDCS combined with a virtual reality-based computerized remediation (VR) is effective for treating negative symptoms in CHR youth, thereby mitigating the enduring functional disability these symptoms cause.

Detailed description

Negative symptoms, which include amotivation, social withdrawal and diminished emotional expression are prominent in youth at clinical high risk (CHR) for psychosis. Negative symptoms lead to significant functional impairment and enduring disability in these youth regardless of subsequent conversion to psychosis. At present, there are no established treatments for negative symptoms. Recent evidence from independent studies, however, suggests two promising novel treatment approaches for negative symptoms, transcranial direct current stimulation (tDCS), and computerized remediation strategies, both of which have revealed significant therapeutic effects on negative symptoms in schizophrenia (SZ). tDCS involves delivery of a low intensity continuous electrical field to the frontal cortex. tDCS is very safe and well tolerated, and is currently being investigated as a treatment for several psychiatric disorders. tDCS is also Health Canada approved for the treatment of major depressive disorder. The primary aim of this randomized controlled trial is to evaluate if tDCS combined with a virtual reality-based computerized remediation (VR), administered three times per week for four weeks, is effective for treating negative symptoms in CHR youth, thereby mitigating the enduring functional disability these symptoms cause.

Conditions

Interventions

TypeNameDescription
DEVICEActive tDCSActive anodal tDCS over the left DLPFC, administered for 30 minutes, three times per week for four weeks.
BEHAVIORALActive VR Motivation TrainingActive computerized treatment with a virtual reality-based motivation training program, administered for 60 minutes, three times per week for four weeks.
DEVICESham tDCSSham anodal tDCS over the left DLPFC, administered for 30 minutes, three times per week for four weeks.
BEHAVIORALSham VR Motivation TrainingSham computerized training in a virtual reality-based environment, administered for 60 minutes, three times per week for four weeks.

Timeline

Start date
2016-10-01
Primary completion
2021-09-01
Completion
2021-09-01
First posted
2016-11-01
Last updated
2020-05-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02951208. Inclusion in this directory is not an endorsement.